Pharmaceutical Technology's In the Lab eNewsletter 11-04-2020

Method-transfer kits help simplify analytical method transfer for global site certifications.

Branching out from roots in industrial biotechnology, Riffyn Data Systems (and its CEO Tim Gardner) is taking the message of data-driven process improvement to biopharma.

The company will collaborate with Rutgers University to test ProSyn as a tool for the production of therapeutic small molecules to respond to biological threats and pandemics.

The companies will work to provide development strategy consultations, system-building, and clinical trial operations, while lessening development time and reducing risk by centralizing project tasks between companies.

Rigaku is featuring its latest x-ray instrumentation at three virtual booths at the virtual 27th International Trade Fair for Laboratory Technology, Analysis, and Biotechnology conference.

Samsung Biologics has adopted Solentim’s cell seeding and cell metric platforms at its new R&D center in San Francisco, CA.

The agreement will allow AbCellera to utilize its full stack, artificial intelligence-powered antibody discovery technology to identify large panels of antibodies against designated targets from Kodiak.

The new service monitors 37 types of alarms and 26 operating parameters to provide a status overview of the freezers.

Mogrify’s new technology platform, EpiMOGRIFY, can predict cellular switches important for determining cell identity, cell maintenance, directed differentiation, and cell conversion.

With the presentation of research supporting the use of PTA technology, BioSkryb also launched its ResolveDNA platform for commercial use at ASHG 2020, held virtually on Oct. 27–30, 2020.